Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Alarm.com
ALRM
$2.71B
| $476K | ﹤0.01% |
+7,486
| New | +$495K |
|
552
Iovance Biotherapeutics
IOVA
$1.82B
| $466K | ﹤0.01% |
58,084
+8,055
| +16% | +$86.3K |
|
553
Century Aluminum
CENX
$4.43B
| $445K | ﹤0.01% |
+26,545
| New | +$452K |
|
554
Viking Therapeutics
VKTX
$3.7B
| $438K | ﹤0.01% |
8,268
+978
| +13% | +$64.1K |
|
|
555
lululemon athletica
LULU
$13.5B
| $435K | ﹤0.01% |
1,455
-3,333,420
| -100% | -$1.11B |
|
|
ARCH
556
DELISTED
Arch Resources, Inc.
ARCH
| $409K | ﹤0.01% |
2,687
-62
| -2% | -$9.96K |
|
557
Rambus
RMBS
$9.87B
| $398K | ﹤0.01% |
6,769
-33,685
| -83% | -$1.93M |
|
558
Kraft Heinz
KHC
$30.7B
| $395K | ﹤0.01% |
12,245
-282
| -2% | -$10.1K |
|
559
Dynatrace
DT
$12.9B
| $379K | ﹤0.01% |
8,481
-3,124
| -27% | -$144K |
|
560
L3Harris
LHX
$51.6B
| $374K | ﹤0.01% |
1,665
-689
| -29% | -$149K |
|
561
Danaher
DHR
$137B
| $371K | ﹤0.01% |
1,483
-31
| -2% | -$7.83K |
|
562
Mettler-Toledo International
MTD
$28.6B
| $328K | ﹤0.01% |
235
-87
| -27% | -$119K |
|
563
CleanSpark
CLSK
$3.53B
| $327K | ﹤0.01% |
+20,491
| New | +$344K |
|
564
Hexcel
HXL
$7.79B
| $315K | ﹤0.01% |
5,038
-3,980
| -44% | -$267K |
|
565
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $306K | ﹤0.01% |
+6,200
| New | +$308K |
|
566
Vanguard Morningstar Growth ETF
VUG
$220B
| $303K | ﹤0.01% |
4,866
-1,002
| -17% | -$58.4K |
|
567
ON Semiconductor
ON
$31.8B
| $303K | ﹤0.01% |
4,425
-77,053
| -95% | -$5.41M |
|
568
NXP Semiconductors
NXPI
$57.8B
| $297K | ﹤0.01% |
1,103
| – | – |
|
569
Starwood Property Trust
STWD
$5.92B
| $275K | ﹤0.01% |
14,525
-336
| -2% | -$6.55K |
|
570
MasTec
MTZ
$21.1B
| $265K | ﹤0.01% |
2,479
| – | – |
|
571
Kura Sushi USA
KRUS
$560M
| $253K | ﹤0.01% |
+4,014
| New | +$405K |
|
572
Array Technologies
ARRY
$803M
| $115K | ﹤0.01% |
11,192
-372,806
| -97% | -$4.73M |
|
573
Align Technology
ALGN
$12.1B
| – | – |
-100,300
| Closed | -$32.9M |
|
574
Baxter International
BAX
$13.5B
| – | – |
-776,880
| Closed | -$33.2M |
|
575
BHP
BHP
$215B
| – | – |
-179,970
| Closed | -$10.4M |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.